We have determined the frequency of EWS fusion tran- (J. Clin. Invest. 1994. 94:489-496.)
Introduction
Ewing's sarcoma (ES)' is a highly malignant tumor of bone and soft tissues that most often affects young adolescents (1). Approximately 83% of all cases are associated with a t( 1l;22)(q24;q12) reciprocal translocation (2) (3) (4) . Cytogenetically identical translocations have been described in other small round cell tumors (SRCT) such as primitive neuroectodermal tumor (PNET), peripheral neuroepithelioma (PN), and Askin's tumor (AT) (5) . The recent cloning of the EWS and Fliu genes disrupted by the t( 11;22)(q24;q12) reciprocal translocation characteristic of these SRCT has provided new insight into possible mechanisms of tumorigenesis in solid tumors (6) . Further, the cloning of hybrid fusion transcripts between EWS and the ATF-1 transcription factor gene in malignant melanoma of soft parts with a balanced t( 12; 22)(q13;q12) translocation (7), the fusion of TLS (translocated in liposarcoma) gene with CHOP gene (member of the c/EBP family of transcriptional activators) as a result of the t(12;16)(q13;pll) translocation in myxoid liposarcoma (8) , and the fusion of PAX3 gene to a member of the forkhead gene family in alveolar rhabdomyosarcomas with a t(2; 13)(q35;q14) translocation (9, 10) suggest a common mechanism of activation of transcription factors that is responsible for development of different tumor types.
Human Fill (11) is a member of the ETS family of transcription factors that exhibit homology within a conserved DNA-binding domain, termed the 3'-ETS domain (12) . EWS (6) is a gene of unknown function with extensive sequence similarity to TLS (8) . Both belong to a new subclass of RNAbinding proteins that contain a conserved 80-amino acid domain in their carboxyl terminus (13) . The ES-and PNETassociated t( 1 1;22)(q24;q12) translocation results in a hybrid mRNA transcribed from the derivative chromosome 22, in which the 3' DNA-binding domain of Flil replaces the 3' RNAbinding domain of EWS (6) . Hybrid EWS-Flil constructs induce malignant transformation when introduced into murine fibroblasts ( 14) . EWS-Flil fusion genes are heterogeneous since three different breakpoints in Fliu and two breakpoints in EWS have been described so far, resulting in four unique fusion sequences (6, 14) . The incidence of the different fusion transcripts in a large number of patients has not yet been determined. Variant and complex translocations have been reported in 9% of all ES and PNET cases (4, 15) . In most instances they involve chromosome 22ql2, suggesting that the fusion gene on the derivative chromosome 22 is related to tumorigenesis. Molecular studies published to date demonstrated that all ES and PNET with typical t( 11;22)(q24;ql2) translocations and one ES cell line with a complex t( 1 1;22; 14) translocation contained EWS-Flil fusion transcripts (6, 14, 16) . Rearrangements of the EWS and Fliu genes were also found in two tumors with variant t(7;22) and t (14;22) translocations and in one tumor with a normal karyotype (17) . These findings are similar to the cases of chronic myeloid leukemia in which cytogenetic analysis does not demonstrate the typical t(9;22)(q34;ql 1 ) translocation yet contains bcr-abl chimeric transcripts (18). Variants of specific chromosomal translocations in multiple leukemia subtypes have been reported. The cloning of some of these rare variant translocations has led to the discovery of new genes that share sequence homology and/or common motifs with the gene disrupted by the "typical" translocation. A notable example is the group of translocations that fuse the MLL gene on llq23 (19) (20) (21) to genes from a variety of different chromosomes (22) . These prepared as described previously (25) . Overlapping YAC clones A125B12 and B19C12 from the Washington University human genomic YAC library were shown previously to be colinear and to contain the human erg gene (29) . To confirm that the YAC strains A125B12 and B19C12 contained the desired human insert, PCR analysis with two sets of primers corresponding to the 5' and 3' regions of the human erg gene was performed. Primers for the erg 5' region were erg5S (5'-CCTCTCGGTTATTCCAGGATC-3') (forward) and erg5A (5'-GTCCGGGACAGTCTGAATCAT-3') (reverse). Primers for the erg 3' region were erg3S (5'-TTCAAGATGACGGATCCCGAC-3') (forward) and primer 21.9 (reverse). Fluorescent in situ suppression hybridization (FISSH) analysis using YAC clones A125B12 and B19C12 was carried out as reported (30) . For two-color FISSH, YAC A125B12 DNA was labeled with biotin-1l-dUTP (ENZO Diagnostics, Syosset, NY), and YAC B19C12 DNA was labeled with digoxigenin-l1-dUTP (Boehringer Mannheim Corp., Indianapolis, IN) by random priming. Hybridization and posthybridization washes of the slides were carried out as described (25) . After posthybridization washes, slides hybridized only to biotin-labeled probes were incubated in avidin-fluorescein as described (25) . Slides hybridized to both biotin-and digoxigenin-labeled probes were amplified and detected as described (31) . (Table I) 22.1 and 11.3 was 421 bp in size (Fig. 1 A) . Nucleotide sequence analysis of the hybrid transcript revealed in-frame junctions between EWS codon 265 and Flil codon 197, which is identical to type 2 fusion described previously (6) . Amplification of SK-PN-LI cDNAs resulted in a product of 181 bp derived from the fusion of EWS with the human erg gene, located on chromosome 21 ( Fig. 1 A) of EWS (Ser) and the G in the second position of codon 192 of erg (Gly), creating a new AGC codon for a serine residue (Fig. 2, A and B) . This region of the erg gene shows 98% homology with the exon 9 region of Fli 1, and we will therefore refer to this fusion as type 9e. Six different erg isoforms have been described, generated by alternative splicing events (28, 33, 34) . The erg moieties cloned in this study are in a region common to all the described erg isoforms. The erg-i cDNA sequence was therefore used for nucleotide and codon numeration (GenBank database accession number M21535). OligodT-primed cDNAs from five SRCT patients that cytogenetically do not contain the typical t( 11; 22)(q24;q12) translocation (Table I) were amplified using the combination of primers 22.3 and 11.3 ( Fig. 1 B) . Tumors Fig. 1 B) . Sequence analysis of the region encompassing the fusion breakpoint revealed an in-frame junction between the first base (G) of codon 349 of EWS (Gly) and the A in the second position of codon 133 of erg (Asp), creating a new GAT codon for an asparagine residue (Fig. 2, A Fig. 4 . One der (22) is similar to the der(22) seen as a result of the typical t(11;22)(q24;ql2) translocation. RT-PCR amplification with primers 22.3 and 11.3 ( Fig. 1 B) produced a 202-bp fragment resulting from an in-frame junction between the A in position one of EWS codon 265 (Ser) and the A in position 2 of Fill codon 261 (D), the first codon of Fill exon 8 (Fig. 2, A (Fig. 1 C) and in three cell lines (Fig. 1 A) (Fig. 1  C) . Our RT-PCR assay did not reveal the presence of the type 4 fusion in PN cell line TC-32, which had been described previously (14) . Despite amplification of the P-actin gene (Fig. 1   C) Thomas, manuscript submitted for publication), we determined the genomic organization and exon structure of the Flil gene and showed that it spans 120 kb of genomic DNA and is encoded by nine exons. Flil exon 9 encodes the ETS domain and begins with a conserved glycine codon that is split by the 8th intron/9th exon junction between nucleotides in position one and two (G/GA). Although the genomic structure and exon organization of the human erg gene have not been determined yet, the striking amino acid sequence identities and the high degree of conservation of intron/exon boundaries found for the other members of ETS family for which the genomic structure is known (Flil, ETS1 and ETS2) imply that erg has an exon structure similar to that of Flil. Furthermore, analysis of the EWS-erg fusions we have isolated indicates two potential exon/ intron boundaries. Flil codon 219 (asparagine), which is split in EWS-Flil type 1 and 3 fusions (6) , is interrupted by an intron/exon junction. In the EWS-erg fusion types le and 3e, we found erg codon 133 (asparagine) to be split between the G in the first position and the A in the second position, indicating a potential intron/exon junction. Another intron/exon junction could interrupt codon 192 of erg (glycine) between the G in the first position and the G in the second position which was found to be fused to EWS in EWS-erg fusion type 9e. This fusion isoform, connecting the NH2-terminal domain of EWS directly to the erg ETS domain, has not been described for Flil and may indicate that the ETS domain itself is sufficient to induce transformation. In fact, similar studies (37) (38) (39) have demonstrated that the EWS/Flil chimeric protein is a transcriptional activator, suggesting that it deregulates the target genes of Flil.
Results

Identification ofdistinct EWS-Flil and EWS-ergfusion isoforms in ES and
The mapping of marker D21S60 to the erg YAC A125B 12 (29) gives us additional information regarding the genomic organization of erg. In an integration map of human chromosome 21, D21S60 is located centromeric to the erg gene (40) . In addition to our PCR results, this evidence strongly suggests that the erg gene is transcribed in a telomere to centromere direction. Since a simple balanced translocation would juxtapose the 5' region of EWS to the 5' end of erg and not the 3' end, this putative erg orientation suggests that a productive EWS-erg fusion requires a complex chromosomal rearrangement. Additional FISSH studies with chromosome-specific painting probes and probes encompassing or flanking the translocation breakpoints will be necessary to precisely define the dynamics of these chromosomal rearrangements.
Another rationale for this study was to analyze the incidence of the different fusion types in a spectrum of tumors with known phenotype. The breakpoints resulting in EWS/Flil type 1 and type 2 fusions appear to be, by far, the most common, and the occurrence of either type 1 or 2 does not seem to be correlated to whether the tumors are considered to be ESs or PNETs. Although we have analyzed a significant number of tumors, analysis of a larger series is necessary to determine whether the occurrence of distinct fusion types is a random event. Considering the number of novel fusion transcripts we have identified in a relatively small number of cases, we predict that additional studies will probably reveal other fusion isoforms occurring between EWS-Flil, EWS-erg, and fusion of EWS with genes on other chromosomes. Further biological studies are needed to determine the role of the fusion transcripts in the development of these tumors. At present, RT-PCR and FISSH clearly provide a sensitive means by which to identify the molecular events involved in the standard, variant, and masked translocations in ES and PNET. 
